Tag: #Global Trends

Xoma Royalty, a company that has recently established a business strategy centered on acquiring distressed biotechnology firms, has secured its... Read more

On December 15, 2025, Sanofi announced two significant strategic collaborations aimed at strengthening its advanced therapeutic development pipelines. 1. Agreement... Read more

The global pharmaceutical corporation, Pfizer, has issued a revenue projection for 2026 in the range of $59.5 billion to $62.5... Read more

Ambros Therapeutics, a newly launched biotechnology company, debuted with an oversubscribed Series A financing round of $125 million. The firm... Read more

Sanofi has entered into a licensing agreement with Adel, a clinical-stage biotech based in Seoul, South Korea, for the development... Read more

Alphyn Biologics, a US-based biotechnology company, has successfully completed a Series B funding round, raising $25 million. The round was... Read more

Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly... Read more

The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with... Read more